Klaus D. Elgert - Publications

Biology Virginia Polytechnic Institute and State University, Blacksburg, VA, United States 

60 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2006 Pressley JS, Elgert KD. Post-chemotherapeutic administration of interleukin-12 retards tumor growth and enhances immune cell function: combination therapy using paclitaxel and IL-12. Cancer Investigation. 24: 351-9. PMID 16777686 DOI: 10.1080/07357900600705276  0.451
2003 Mullins DW, Martins RS, Elgert KD. Tumor-derived cytokines dysregulate macrophage interferon-gamma responsiveness and interferon regulatory factor-8 expression. Experimental Biology and Medicine (Maywood, N.J.). 228: 270-7. PMID 12626771 DOI: 10.1177/153537020322800305  0.722
2001 Mullins DW, Martins RS, Burger CJ, Elgert KD. Tumor cell-derived TGF-beta and IL-10 dysregulate paclitaxel-induced macrophage activation. Journal of Leukocyte Biology. 69: 129-37. PMID 11200057  0.695
2001 Mullins DW, Martins RS, Burger CJ, Elgert KD. Tumor cell-derived TGF-β and IL-10 dysregulate paclitaxel-induced macrophage activation Journal of Leukocyte Biology. 69: 129-137. DOI: 10.1189/Jlb.69.1.129  0.724
1999 Mullins DW, Burger CJ, Elgert KD. Paclitaxel enhances macrophage IL-12 production in tumor-bearing hosts through nitric oxide. Journal of Immunology (Baltimore, Md. : 1950). 162: 6811-8. PMID 10352302  0.676
1998 Mullins DW, Burger CJ, Elgert KD. Tumor growth modulates macrophage nitric oxide production following paclitaxel administration. International Journal of Immunopharmacology. 20: 537-51. PMID 9839658 DOI: 10.1016/S0192-0561(98)00047-2  0.719
1998 Mullins DW, Koci MD, Burger CJ, Elgert KD. Interleukin-12 overcomes paclitaxel-mediated suppression of T-cell proliferation. Immunopharmacology and Immunotoxicology. 20: 473-92. PMID 9805229 DOI: 10.3109/08923979809031511  0.736
1998 Elgert KD, Alleva DG, Mullins DW. Tumor-induced immune dysfunction: the macrophage connection. Journal of Leukocyte Biology. 64: 275-90. PMID 9738653 DOI: 10.1002/Jlb.64.3.275  0.731
1997 Mullins DW, Walker TM, Burger CJ, Elgert KD. Taxol-mediated changes in fibrosarcoma-induced immune cell function: modulation of antitumor activities. Cancer Immunology, Immunotherapy : Cii. 45: 20-8. PMID 9353423 DOI: 10.1007/S002620050396  0.752
1997 Mullins DW, Alleva DG, Burger CJ, Elgert KD. Taxol, a microtubule-stabilizing antineoplastic agent, differentially regulates normal and tumor-bearing host macrophage nitric oxide production. Immunopharmacology. 37: 63-73. PMID 9285245 DOI: 10.1016/S0162-3109(97)00004-0  0.733
1995 Alleva DG, Askew D, Burger CJ, Elgert KD. Macrophage priming and activation during fibrosarcoma growth: expression of c-myb, c-myc, c-fos, and c-fms. Immunological Investigations. 23: 457-72. PMID 7851963 DOI: 10.3109/08820139409066840  0.385
1995 Alleva DG, Walker TM, Elgert KD. Induction of macrophage suppressor activity by fibrosarcoma-derived transforming growth factor-beta 1: contrasting effects on resting and activated macrophages. Journal of Leukocyte Biology. 57: 919-28. PMID 7790775 DOI: 10.1002/Jlb.57.6.919  0.432
1995 Alleva DG, Elgert KD. Promotion of macrophage-stimulated autoreactive T cell proliferation by interleukin-10: counteraction of macrophage suppressor activity during tumor growth. Immunobiology. 192: 155-71. PMID 7782092 DOI: 10.1016/S0171-2985(11)80094-X  0.555
1994 Walker TM, Burger CJ, Elgert KD. Tumor growth alters T cell and macrophage production of and responsiveness to granulocyte-macrophage colony-stimulating factor: partial dysregulation through interleukin-10. Cellular Immunology. 154: 342-57. PMID 8131207 DOI: 10.1006/Cimm.1994.1082  0.601
1994 Alleva DG, Burger CJ, Elgert KD. Tumour growth causes suppression of autoreactive T-cell proliferation by disrupting macrophage responsiveness to interferon-gamma. Scandinavian Journal of Immunology. 39: 31-8. PMID 7904773 DOI: 10.1111/J.1365-3083.1994.Tb03336.X  0.492
1993 Askew D, Burger CJ, Elgert KD. Tumor growth and adherence change the expression of macrophage Mac-2. Cancer Letters. 69: 67-74. PMID 8481895 DOI: 10.1016/0304-3835(93)90034-7  0.497
1993 Alleva DG, Burger CJ, Elgert KD. Tumor growth increases Ia- macrophage synthesis of tumor necrosis factor-alpha and prostaglandin E2: changes in macrophage suppressor activity. Journal of Leukocyte Biology. 53: 550-558. PMID 8388910 DOI: 10.1002/Jlb.53.5.550  0.523
1993 Alleva DG, Askew D, Burger CJ, Elgert KD. Fibrosarcoma‐induced increase in macrophage tumor necrosis factor α synthesis suppresses T cell responses Journal of Leukocyte Biology. 54: 152-160. PMID 8360594 DOI: 10.1002/Jlb.54.2.152  0.561
1993 Alleva DG, Burger CJ, Elgert KD. Interferon-gamma reduces tumor-induced Ia- macrophage-mediated suppression: role of prostaglandin E2, Ia, and tumor necrosis factor-alpha. Immunopharmacology. 25: 215-27. PMID 8354638 DOI: 10.1016/0162-3109(93)90050-Z  0.493
1993 Askew D, Burger CJ, Elgert KD. Tumor-induced modulation of macrophage class II MHC molecule mRNA expression. Molecular Immunology. 30: 911-20. PMID 8341283 DOI: 10.1016/0161-5890(93)90015-4  0.402
1993 Walker TM, Burger CJ, Elgert KD. Tumor growth alters macrophage responsiveness to macrophage colony-stimulating factor during reactivity against allogeneic and syngeneic MHC class II molecules. Immunological Investigations. 22: 463-76. PMID 8262568 DOI: 10.3109/08820139309063424  0.479
1993 Alleva DG, Burger CJ, Elgert KD. Tumor-induced macrophage tumor necrosis factor-alpha production suppresses autoreactive T cell proliferation. Immunobiology. 188: 430-45. PMID 8244447 DOI: 10.1016/S0171-2985(11)80225-1  0.482
1993 Walker TM, Yurochko AD, Burger CJ, Elgert KD. Ia- macrophages and cytokine networks contribute to tumor-induced suppression of CD4+ autoreactive T cells. Immunological Investigations. 22: 169-87. PMID 8099569 DOI: 10.3109/08820139309063401  0.768
1992 Walker TM, Yurochko AD, Burger CJ, Elgert KD. Macrophages stimulated by receptor-ligand interactions exhibit differences in cell-cycle kinetics during tumor growth: stimulation at Mac-1 and Mac-3 receptors alters DNA synthesis. Immunology Letters. 31: 217-25. PMID 1548036 DOI: 10.1016/0165-2478(92)90117-7  0.663
1992 Walker TM, Yurochko AD, Burger CJ, Elgert KD. Cytokines and suppressor macrophages cause tumor-bearing host CD8+ T cells to suppress recognition of allogeneic and syngeneic MHC class II molecules. Journal of Leukocyte Biology. 52: 661-9. PMID 1464737 DOI: 10.1002/Jlb.52.6.661  0.711
1992 Walker TM, Yurochko AD, Burger CJ, Elgert KD. Tumor growth changes the contribution of granulocyte-macrophage colony-stimulating factor during macrophage-mediated suppression of allorecognition. Immunobiology. 185: 427-39. PMID 1452214 DOI: 10.1016/S0171-2985(11)80085-9  0.724
1991 Askew D, Burger CJ, Elgert KD. Modulation of alloreactivity by Mac-1+, -2+, and -3+ macrophages from normal and tumor-bearing hosts: flow cytofluorometrically separated macrophages. Immunobiology. 182: 1-10. PMID 2151512 DOI: 10.1016/S0171-2985(11)80578-4  0.445
1990 Yurochko AD, Burger CJ, Elgert KD. Two-color flow cytometric analysis of the expression of MAC and MHC Class II antigens on macrophages during tumor growth Cytometry. 11: 725-735. PMID 2200657 DOI: 10.1002/Cyto.990110610  0.722
1990 Yurochko AD, Burger CJ, Elgert KD. Tumor modulation of autoreactivity: Decreased macrophage and autoreactive T cell interactions Cellular Immunology. 127: 105-119. PMID 2138515 DOI: 10.1016/0008-8749(90)90118-B  0.744
1990 Askew D, Yurochko AD, Burger CJ, Elgert KD. Normal and tumor-bearing host macrophage responses: variability in accessory function, surface markers, and cell-cycle kinetics Immunology Letters. 24: 21-29. PMID 1695610 DOI: 10.1016/0165-2478(90)90031-K  0.675
1990 Yurochko AD, Askew D, Burger CJ, Elgert KD. Normal and tumor-bearing host splenic macrophage responses to lipopolysaccharide Immunological Investigations. 19: 41-55. PMID 1692569 DOI: 10.3109/08820139009042024  0.669
1989 Malick AP, Yurochko AD, Burger CJ, Askew D, Elgert KD. Tumor-induced variations in a high molecular weight inhibitory monokine. Immunobiology. 178: 361-79. PMID 2785483 DOI: 10.1016/S0171-2985(89)80059-2  0.74
1989 Yurochko AD, Pyle RH, Elgert KD. Changes in macrophage populations: Phenotypic differences between normal and tumor-bearing host macrophages Immunobiology. 178: 416-435. PMID 2654009 DOI: 10.1016/S0171-2985(89)80063-4  0.712
1989 Yurochko AD, Nagarkatti PS, Nagarkatti M, Elgert KD. Tumor-induced alteration in macrophage accessory cell activity on autoreactive T cells Cancer Immunology Immunotherapy. 30: 170-176. PMID 2598186 DOI: 10.1007/Bf01669426  0.743
1987 Malick AP, Elgert KD, Garner RE, Adkinson NF. Prostaglandin E2 production by Mac-2+ macrophages: tumor-induced population shift. Journal of Leukocyte Biology. 42: 673-81. PMID 2960767 DOI: 10.1002/Jlb.42.6.673  0.483
1987 Garner RE, Malick AP, Yurochko AD, Elgert KD. Shifts in macrophage (M phi) surface phenotypes during tumor growth: association of Mac-2+ and Mac-3+ M phi with immunosuppressive activity. Cellular Immunology. 108: 255-68. PMID 2957065 DOI: 10.1016/0008-8749(87)90211-5  0.712
1986 Garner RE, Elgert KD. Changes in splenic macrophage Mac antigen expression during tumor growth: a kinetic study of accessory cell function and antigen-defined phenotypes. Journal of Leukocyte Biology. 40: 709-24. PMID 3537182 DOI: 10.1002/Jlb.40.6.709  0.527
1986 Garner RE, Malick AP, Elgert KD. Variations in macrophage antigen phenotype: a correlation between Ia antigen reduction and immune dysfunction during tumor growth. Journal of Leukocyte Biology. 40: 561-74. PMID 3464674 DOI: 10.1002/Jlb.40.5.561  0.54
1986 Roberson AM, Elgert KD. Splenocytes from tumor-bearing Corynebacterium parvum treated mice maintain interleukin-2 and -3 activity. Cancer Immunology, Immunotherapy : Cii. 22: 49-55. PMID 2939948 DOI: 10.1007/Bf00205716  0.439
1984 Burger CJ, Elgert KD. Interleukin 3 activity in tumor-bearing hosts: decreased splenocyte production of and responsiveness to IL 3. Immunological Communications. 13: 255-68. PMID 6430790 DOI: 10.3109/08820138409025466  0.349
1984 Garner RE, Malick AP, Connolly KM, Elgert KD. In vivo assessment of tumor-induced nonspecific suppression of contact sensitivity. II. Regulation by cytokines and T cells via adoptive transfer. Cancer Immunology, Immunotherapy : Cii. 18: 135-7. PMID 6391655 DOI: 10.1007/Bf00205748  0.49
1984 Malick AP, Garner RE, Black SP, Elgert KD. Normal and tumor-bearing host macrophage factor-mediated modulation of mixed-lymphocyte reaction responsiveness: separation of T-lymphocyte subset susceptibility to enhancing and inhibitory factors. Cellular Immunology. 85: 549-55. PMID 6232006 DOI: 10.1016/0008-8749(84)90267-3  0.547
1984 Burger CJ, Elgert KD, Farrar WL. Interleukin 2 (IL-2) activity during tumor growth: IL-2 production kinetics, absorption of and responses to exogenous IL-2. Cellular Immunology. 84: 228-39. PMID 6231106 DOI: 10.1016/0008-8749(84)90095-9  0.627
1984 Denbow CJ, Conroy JM, Elgert KD. Macrophage-derived prostaglandin E modulation of the mixed-lymphocyte reaction: An anomaly of increased production and decreased T-cell susceptibility during tumor growth Cellular Immunology. 84: 1-13. PMID 6230157 DOI: 10.1016/0008-8749(84)90071-6  0.533
1983 Burger CJ, Elgert KD. Level of macrophage induction during tumor growth: primed or activated? Immunological Communications. 12: 285-90. PMID 6885106 DOI: 10.3109/08820138309050750  0.477
1983 Connolly KM, Elgert KD, Conroy JM, Vogel SN, Rutherford RB. Immunoregulation of the mixed lymphocyte reaction by macrophage-derived factors: functional and biochemical separation of enhancing and inhibitory factors. Immunobiology. 164: 144-59. PMID 6221994 DOI: 10.1016/S0171-2985(83)80006-0  0.34
1982 Farrar WL, Elgert KD, Burger CJ. Tumor-induced impairment of T-cell-independent B-cell blastogenesis and DNA polymerase activity. Proceedings of the Society For Experimental Biology and Medicine. Society For Experimental Biology and Medicine (New York, N.Y.). 169: 127-34. PMID 6461011 DOI: 10.3181/00379727-169-41320  0.651
1981 Willard KE, Elgert KD. Glucocorticosteroid modification of lymphocyte blastogenesis in tumor-bearing hosts. Cellular Immunology. 55: 355-65. PMID 6448696 DOI: 10.1016/0008-8749(80)90167-7  0.574
1980 Elgert KD. In vivo assessment of tumor-induced nonspecific suppression of contact sensitivity. I. Correlation with in vitro studies. Cellular Immunology. 49: 395-401. PMID 7353215 DOI: 10.1016/0008-8749(80)90042-8  0.479
1980 Elgert KD, Connolly KM. Enhancement of T cell MLR reactivity by addition of macrophage supernatants from tumor-bearing mice. Oncology. 37: 101-6. PMID 6444706 DOI: 10.1159/000225414  0.571
1979 Farrar WL, Elgert KD. In vitro immune blastogenesis during contact sensitivity in tumor-bearing mice. II. Mechanism of inhibition. Cellular Immunology. 40: 365-75. PMID 309800 DOI: 10.1016/0008-8749(78)90344-1  0.691
1979 Elgert KD, Farrar WL. In vitro immune blastogenesis during contact sensitivity in tumor-bearing mice. I. Description of progressive impairment and demonstration of splenic suppressor cells. Cellular Immunology. 40: 356-64. PMID 309799 DOI: 10.1016/0008-8749(78)90343-X  0.636
1979 Connolly KM, Elgert KD. Regulation of T-cell mixed lymphocyte reaction reactivity: demonstration of enhancing and inhibitory activity in tumor bearing host macrophages supernatants. Cellular Immunology. 45: 94-107. PMID 156588 DOI: 10.1016/0008-8749(79)90365-4  0.506
1979 Connolly KM, Elgert KD. Reversal of macrophage-augmented MLR reactivity by tumor-induced splenic suppressor T cells and their soluble factor(s). Cellular Immunology. 44: 99-108. PMID 156587 DOI: 10.1016/0008-8749(79)90031-5  0.531
1979 Gebel HM, Barrett JT, Elgert KD, Campbell BJ, Finke JH. Inactivation of Complement by Loxosceles Reclusa Spider Venom The American Journal of Tropical Medicine and Hygiene. 28: 756-762. DOI: 10.4269/ajtmh.1979.28.756  0.603
1979 Connolly KM, Farrar WL, Elgert KD. Tumor-Induced Dualistic Suppressor Cell Regulation: Macrophages And Suppressor T Cells Cell Biology and Immunology of Leukocyte Function. 701-705. DOI: 10.1016/B978-0-12-569650-0.50094-2  0.682
1978 Farrar WL, Elgert KD. Inhibition of mitogen and immune blastogenesis by two distinct populations of supressor cells present in the spleens of fibrosarcoma-bearing mice: adoptive transfer of suppression. International Journal of Cancer. 22: 142-51. PMID 308934 DOI: 10.1002/Ijc.2910220207  0.657
1978 Elgert KD, Connolly KM. Macrophage regulation of the T-cell allogeneic response during tumor growth. Cellular Immunology. 35: 1-14. PMID 145897 DOI: 10.1016/0008-8749(78)90121-1  0.586
1975 Elgert KD, Ross MA, Campbell BJ, Barrett JT. Immunological studies of Brown recluse spider venom. Infection and Immunity. 10: 1412-9. PMID 4140161 DOI: 10.1128/Iai.10.6.1412-1419.1974  0.623
1973 Wright RP, Elgert KD, Campbell BJ, Barrett JT. Hyaluronidase and esterase activities of the venom of the poisonous brown recluse spider. Archives of Biochemistry and Biophysics. 159: 415-26. PMID 4206202 DOI: 10.1016/0003-9861(73)90469-4  0.633
Show low-probability matches.